Middle East Pharmaceutical Industries Co. (4016.SR)
SAR 119.8
(-0.33%)
SAR 119.8
(-0.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 444.89 Million SAR | 0.55% |
| 2022 | 442.45 Million SAR | 6.12% |
| 2021 | 416.92 Million SAR | 12.49% |
| 2020 | 370.63 Million SAR | 30.83% |
| 2019 | 283.28 Million SAR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 455.83 Million SAR | 2.46% |
| 2024 Q2 | 465.95 Million SAR | 2.22% |
| 2023 Q4 | 444.89 Million SAR | 0.0% |
| 2023 Q1 | - SAR | -100.0% |
| 2023 Q3 | 444.89 Million SAR | 4.48% |
| 2023 Q2 | 425.82 Million SAR | 0.0% |
| 2023 FY | 444.89 Million SAR | 0.55% |
| 2022 Q3 | 442.45 Million SAR | 0.0% |
| 2022 FY | 442.45 Million SAR | 6.12% |
| 2022 Q4 | 442.45 Million SAR | 0.0% |
| 2022 Q1 | - SAR | 0.0% |
| 2021 FY | 416.92 Million SAR | 12.49% |
| 2020 FY | 370.63 Million SAR | 30.83% |
| 2019 FY | 283.28 Million SAR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Al-Dawaa Medical Services Company | 4.7 Billion SAR | 90.549% |
| Nahdi Medical Company | 5.37 Billion SAR | 91.717% |
| Al-Razi Medical Co. | 45.41 Million SAR | -879.574% |
| Almujtama Alraida Medical Co. | 441.99 Million SAR | -0.656% |